The Trader 

Market Outlook: US Pharma executives found guilty

The Trader

The New York Times reports that yesterday, at a federal court in Boston, founder of opioid drug maker Insys Therapeutics, John Kapoor and four of his top executives, were guilty of racketeering. Not only had they bribed doctors to prescribe their very strong and highly addictive nasal spray Subsys, but had misled health insurers about patents’ need for the medication. This marks another step in the fight against an opioid crisis in the US which has killed 200,000 people over the last two decades.

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Register
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now